VistaGen TherapeuticsVTGN 
$3.520.00%24h
0.00%24h
Global rank21603
Market cap$24.50M
Change 7d-2.49%
YTD Performance-30.30%
SP500 benchmarkUnderperform
P/E-0.41
P/S-107.77
Revenue-$227.30K
Earnings-$59.25M
Dividend yield-
Main Sector
Healthcare
Category
VistaGen Therapeutics VTGN Total Debt
VTGN Total Debt in 2022: $2.13M
According to VistaGen Therapeutics latest financial reports the total debt is $2.13M, an decrease of -18.35% to 2022. At the end of 2022 company had $2.61M total debt. This figure represents the debts and financial obligations that VistaGen Therapeutics combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
VistaGen Therapeutics VTGN Total Debt History from 2023 to 2022
-
Value:-
VTGN Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $2.13M | -18.35% |
| 2022 | $2.61M | -22.25% |
| 2021 | $3.35M | -9.89% |
| 2020 | $3.72M | 58925.40% |
| 2019 | $6.30K | - |
View the Top Total Debt Stocks 
